On weekends, I twisted my hips and adjusted it to the point where it hurt to sit and stand for long periods of time.
I told my wife: “I really don’t want to get old because I just fall apart.”
It was a bit melodramatic, but living in South Florida, people learned to make great efforts to avoid the aging process.
So, as always, I started thinking about it from an investment perspective.
Using Adam O’Dell’s 6-element Green Zone Rating System, we found a company developing aesthetic medicine products (products that help us look younger than us).
we are “strongThis means that the company’s stock is at least in good shape to outperform the wider market. Twice in the next 12 months..
And anti-aging trends will push the company even further in the coming years.
There is money in anti-aging treatment
Millions of people around the world are looking for ways to stop the trend of aging.
To be clear, I’m not one of those people (I just want my salt and pepper hair to be all gray at this point).
Products range from creams and serums to injections and flocking.
The companies that develop and sell these products are set up to make a lot of money.
The anti-aging market in 2020 (money spent on products to make you look younger) was $ 58.5 billion worldwide.
By 2026, the market is expected to grow to $ 88.3 billion, increasing its market value by 51%. Research company IMARC Group..
Investor In this trend, you can make strong profits by investing in this one company.
Anti-aging stock to buy: InMode Ltd.
InMode Ltd. (Nasdaq: INMD) Is an Israeli-based company that develops and sells minimally invasive anti-aging medical products.
From liposuction to skin rejuvenation cellulite treatment, InMode offers products in more than 50 countries, including the United States, Canada, Spain, Australia and France.
In 2020, the company reported total revenue of $ 206 million.
It is estimated that InMode’s total revenue could reach $ 430.5 million by 2023, increasing annual top-line revenue by 109%.
This is because more and more people are using the product as they get older.
InMode stock trading above all moving averages
Currently, InMode’s stock price (red line) is trading above the moving averages of the 200th (orange line), 50th (green line) and 10th (pink line).
This suggests that the INMD remains a bullish pattern as it is just below the 52-week high of $ 134.11.
In the last 12 months, INMD prices have skyrocketed by more than 315% and continue to rise.
InMode Stock Price Valuation
InMode scores using Adam’s 6-element Green Zone Rating System 71 in total..So we are “bullish” on this anti-aging stock and expect to outperform the wider market. Twice in the next 12 months..
Green InMode rate:
- quality — InMode has a very high return on assets, capital and investment (all over 40%) compared to the average for other medical device industries. These are all negative.Company earns 99 About quality.
- growth — InMode’s annual revenue increased 32% from $ 156.4 million in 2019 to $ 206.1 million in 2020. The company’s three-year earnings per share growth rate is almost 100%.It earns 90 With this metric.
- Momentum — InMode’s share price has risen 90% since it fell 23% in the first half of May and is on fire.Company earns 65 With momentum.
InMode is Volatility 49 May price cuts The size is 45 The market capitalization is about $ 5 billion.
The company also Value 16 Price earnings ratio, price-to-book value ratio, and price-to-book value ratio are all above the industry average.
Conclusion: We are all old. It’s a fact of life.
But more and more people are trying to stop the aging process by the necessary means. InMode’s sales and profits will only be higher.
Therefore, InMode Ltd. Is an anti-aging stock for finding portfolios.
Matt Clark, CMSA®
Survey analyst, Money & Market
Matt Clark is a research analyst Money & Market.. He is a Certified Capital Markets & Securities Analyst at the Corporate Finance Institute and In search of alpha..Before joining Money & Market, He has been a journalist and editor for 25 years, responsible for college sports, business and politics.
Anti-Aging Stock Is Bullish for the $80B Industry Boom Source link Anti-Aging Stock Is Bullish for the $80B Industry Boom